OUR MODEL
CERTIFIED SAFE IBOGAINE PROVISION
COMPASSIONATE REHABILITATION
LIFE-AFFIRMING AFTERCARE
mPath fills a critical gap by providing legal, ethically sourced, pharmaceutical-grade Ibogaine, standardizing drug consistency and dosage, facilitating safer treatment at the many centers currently offering Ibogaine therapy worldwide.
mPath is also leading the effort to standardize protocols for Ibogaine treatment, rehabilitation, aftercare and co-therapies at partner hospitals and clinics in Jamaica, opening new clinics worldwide as demand grows and regulations permit.

LASTING RECOVERY
ETHICAL • COMPASSIONATE
Ineffective treatments lead to continued abuse and prolonged suffering. Conventional pharmaceutical “Medication-Assisted-Treatments” don’t consider causation or brain chemistry, often leading patients to self-medicate with illicit drugs or seek treatment at foreign clinics using risky black/gray market iboga powder.
ESTABLISHED • GROWING
GMP-CERTIFIED PRODUCTION
mPath Therapeutics was launched by legacy executives steeped in holistic medicines with established pharmaceutical operations on-island. Over $5M USD was invested in state of the art manufacturing facilities, modern offices and key licenses. mPath access to these valuable assets accelerates drug development, production & distribution to a growing international customer base.


WHERE TYPICAL REHAB FAILS
RE-DEFINING RECOVERY
mPath will next be administering clinical trials at our facilities in Jamaica with up to 20 veterans, at no cost. And while veterans are more commonly associated with traumatic disorders, 80% of Americans suffering from PTSD are not veterans.
mPath aftercare & co-therapy retreats personalize decompression and nurture empowerment for patients, families, and caregivers, providing tools for the journey to full recovery, together—anchored in a supportive community for lasting results.
NEXT PHASE
GROWTH STAGE
mPath Therapeutics Corporation is currently raising a seed round to fund Stage 1 & 2 developments:
1) Begin production, in-house at our existing GMP-certified facility, the world’s first government-approved, pharma-grade, dosage-precise Ibogaine.
2) Develop our intellectual property portfolio, including treatment & aftercare protocols from our headquarters in Jamaica, triggering a license to begin on-island patient treatment, commencing with a cohort of 20-veterans suffering PTSD.
If you have been personally affected by trauma or addiction—that’s why we’re here and we want to hear from you.
If you would like to discuss joining us in this seed round, please contact us using this link and we will reply directly.
If you’re seeking safe relief from trauma and related disorders, please email us here.
